CYTOKINETICS, INCORPORATED Financing Cash Flow
CYTOKINETICS, INCORPORATED (CYTK) reported Financing Cash Flow of $800.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $792.86M, a 909.58% increase year-over-year.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $7.77M, a 63.44% increase year-over-year.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $110.70M, a 4543.67% increase year-over-year.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $330.47M, a 9548.64% increase year-over-year.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for fiscal 2025 was $524.46M, a 43.64% decline from fiscal 2024.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for fiscal 2024 was $930.61M, a 320.49% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for fiscal 2023 was $221.32M, a 57.12% decline from fiscal 2022.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) financing activities for fiscal 2022 was $516.17M, a 61.31% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 167 month | Net Cash Provided by (Used in) Financing Activities 170 month | Net Cash Provided by (Used in) Financing Activities 173 month | Net Cash Provided by (Used in) Financing Activities 176 month | Net Cash Provided by (Used in) Financing Activities 179 month | Net Cash Provided by (Used in) Financing Activities 182 month | Net Cash Provided by (Used in) Financing Activities 185 month | Net Cash Provided by (Used in) Financing Activities 188 month | Net Cash Provided by (Used in) Financing Activities 191 month | Net Cash Provided by (Used in) Financing Activities 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $792.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $800.63M 10-Q · filed 2026-08-06 | $911.33M derived: sum of 3 quarters · filed 2026-08-06 | $1.24B derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2026-03-31 | $7.77M 10-Q · filed 2026-05-05 | $118.47M derived: sum of 2 quarters · filed 2026-05-05 | $448.94M derived: sum of 3 quarters · filed 2026-05-05 | $527.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-12-31 | $110.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $441.17M derived: sum of 2 quarters · filed 2026-02-26 | $519.70M derived: sum of 3 quarters · filed 2026-08-06 | $524.46M 10-K · filed 2026-02-26 | ||||||||||
| 2025-09-30 | $330.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $409.00M derived: sum of 2 quarters · filed 2026-08-06 | $413.75M 10-Q · filed 2025-11-05 | $416.14M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-06-30 | $78.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $83.29M 10-Q · filed 2026-08-06 | $85.67M derived: sum of 3 quarters · filed 2026-08-06 | $89.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-03-31 | $4.75M 10-Q · filed 2026-05-05 | $7.14M derived: sum of 2 quarters · filed 2026-05-05 | $10.56M derived: sum of 3 quarters · filed 2026-05-05 | $831.57M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||
| 2024-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.81M derived: sum of 2 quarters · filed 2026-02-26 | $826.82M derived: sum of 3 quarters · filed 2026-02-26 | $930.61M 10-K · filed 2026-02-26 | ||||||||||
| 2024-09-30 | $3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $824.44M derived: sum of 2 quarters · filed 2025-11-05 | $928.23M 10-Q · filed 2025-11-05 | $1.10B derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-06-30 | $821.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $924.80M 10-Q · filed 2025-08-07 | $1.09B derived: sum of 3 quarters · filed 2026-02-26 | $1.15B derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-03-31 | $103.79M 10-Q · filed 2025-05-06 | $272.59M derived: sum of 2 quarters · filed 2026-02-26 | $326.81M derived: sum of 3 quarters · filed 2026-02-26 | $332.29M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2023-12-31 | $168.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $223.02M derived: sum of 2 quarters · filed 2026-02-26 | $228.49M derived: sum of 3 quarters · filed 2026-02-26 | $221.32M 10-K · filed 2026-02-26 | ||||||||||
| 2023-09-30 | $54.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $59.69M derived: sum of 2 quarters · filed 2024-11-07 | $52.52M 10-Q · filed 2024-11-07 | $82.40M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-06-30 | $5.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.70M 10-Q · filed 2024-08-09 | $28.18M derived: sum of 3 quarters · filed 2025-02-27 | $417.20M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-03-31 | -$7.18M 10-Q · filed 2024-05-10 | $22.71M derived: sum of 2 quarters · filed 2025-02-27 | $411.73M derived: sum of 3 quarters · filed 2025-02-27 | $415.14M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2022-12-31 | $29.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $418.90M derived: sum of 2 quarters · filed 2025-02-27 | $422.32M derived: sum of 3 quarters · filed 2025-02-27 | $516.17M 10-K · filed 2025-02-27 | ||||||||||
| 2022-09-30 | $389.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $392.44M derived: sum of 2 quarters · filed 2023-11-03 | $486.28M 10-Q · filed 2023-11-03 | $505.79M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $97.26M 10-Q · filed 2023-08-03 | $116.77M derived: sum of 3 quarters · filed 2024-02-28 | $417.66M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-03-31 | $93.85M 10-Q · filed 2023-05-05 | $113.35M derived: sum of 2 quarters · filed 2024-02-28 | $414.25M derived: sum of 3 quarters · filed 2024-02-28 | $417.42M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2021-12-31 | $19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $320.40M derived: sum of 2 quarters · filed 2024-02-28 | $323.58M derived: sum of 3 quarters · filed 2024-02-28 | $319.98M 10-K · filed 2024-02-28 | ||||||||||
| 2021-09-30 | $300.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $304.07M derived: sum of 2 quarters · filed 2022-11-04 | $300.47M 10-Q · filed 2022-11-04 | $304.12M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$421.00K 10-Q · filed 2022-08-05 | $3.22M derived: sum of 3 quarters · filed 2023-03-01 | $229.55M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-03-31 | -$3.60M 10-Q · filed 2022-05-06 | $45.00K derived: sum of 2 quarters · filed 2023-03-01 | $226.38M derived: sum of 3 quarters · filed 2023-03-01 | $230.54M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2020-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $229.97M derived: sum of 2 quarters · filed 2023-03-01 | $234.13M derived: sum of 3 quarters · filed 2023-03-01 | $234.12M 10-K · filed 2023-03-01 | ||||||||||
| 2020-09-30 | $226.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $230.49M derived: sum of 2 quarters · filed 2021-11-05 | $230.48M 10-Q · filed 2021-11-05 | $351.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-06-30 | $4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $4.15M 10-Q · filed 2021-08-06 | $125.27M derived: sum of 3 quarters · filed 2022-02-25 | $137.13M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-03-31 | -$11.00K 10-Q · filed 2021-05-07 | $121.11M derived: sum of 2 quarters · filed 2022-02-25 | $132.97M derived: sum of 3 quarters · filed 2022-02-25 | $155.36M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2019-12-31 | $121.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $132.98M derived: sum of 2 quarters · filed 2022-02-25 | $155.38M derived: sum of 3 quarters · filed 2022-02-25 | $159.79M 10-K · filed 2022-02-25 | ||||||||||
| 2019-09-30 | $11.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $34.26M derived: sum of 2 quarters · filed 2020-11-06 | $38.67M 10-Q · filed 2020-11-06 | $39.12M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2019-06-30 | $22.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $26.81M 10-Q · filed 2020-08-07 | $27.26M derived: sum of 3 quarters · filed 2021-02-26 | $37.49M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2019-03-31 | $4.42M 10-Q · filed 2020-05-08 | $4.87M derived: sum of 2 quarters · filed 2021-02-26 | $15.09M derived: sum of 3 quarters · filed 2021-02-26 | $18.07M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2018-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $10.68M derived: sum of 2 quarters · filed 2021-02-26 | $13.66M derived: sum of 3 quarters · filed 2021-02-26 | $13.13M 10-K · filed 2021-02-26 | ||||||||||
| 2018-09-30 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $13.21M derived: sum of 2 quarters · filed 2019-11-01 | $12.68M 10-Q · filed 2019-11-01 | $14.88M derived: sum of 4 quarters · filed 2019-11-01 | ||||||||||
| 2018-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.45M 10-Q · filed 2019-08-09 | $4.65M derived: sum of 3 quarters · filed 2019-08-09 | $6.08M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||
| 2018-03-31 | -$524.00K 10-Q · filed 2019-05-09 | $1.67M derived: sum of 2 quarters · filed 2019-05-09 | $3.10M derived: sum of 3 quarters · filed 2019-05-09 | |||||||||||
| 2017-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.63M derived: sum of 2 quarters · filed 2019-03-07 | $225.92M 10-K · filed 2019-03-07 | |||||||||||
| 2017-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $223.72M 10-Q · filed 2018-11-09 | ||||||||||||
| 2017-06-30 | $222.29M 10-Q · filed 2018-08-07 | |||||||||||||
| 2014-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $39.81M 10-Q · filed 2014-08-07 | $47.33M derived: sum of 3 quarters · filed 2014-08-07 | $46.81M derived: sum of 4 quarters · filed 2014-08-07 | ||||||||||
| 2014-03-31 | $39.78M 10-Q · filed 2014-05-07 | $47.30M derived: sum of 2 quarters · filed 2014-05-07 | $46.78M derived: sum of 3 quarters · filed 2014-05-07 | $54.26M derived: sum of 4 quarters · filed 2014-08-07 | ||||||||||
| 2013-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $7.00M derived: sum of 2 quarters · filed 2014-03-07 | $14.48M derived: sum of 3 quarters · filed 2014-08-07 | $14.49M 10-K · filed 2014-03-07 | ||||||||||
| 2013-09-30 | -$516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $6.97M derived: sum of 2 quarters · filed 2014-08-07 | $6.97M 10-Q · filed 2013-11-06 | $7.00M derived: sum of 4 quarters · filed 2014-08-07 | $487.67M 10-Q · filed 2013-11-06 | |||||||||
| 2013-06-30 | $7.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $7.49M 10-Q · filed 2014-08-07 | $7.51M derived: sum of 3 quarters · filed 2014-08-07 | $7.10M derived: sum of 4 quarters · filed 2014-08-07 | $488.19M 10-Q · filed 2013-08-07 | |||||||||
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-07 | $30.00K derived: sum of 2 quarters · filed 2014-05-07 | -$382.00K derived: sum of 3 quarters · filed 2014-05-07 | $55.66M derived: sum of 4 quarters · filed 2014-05-07 | $480.70M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$387.00K derived: sum of 2 quarters · filed 2014-03-07 | $55.66M derived: sum of 3 quarters · filed 2014-03-07 | $58.33M 10-K · filed 2014-03-07 | $480.70M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | -$412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $55.63M derived: sum of 2 quarters · filed 2013-11-06 | $58.30M 10-Q · filed 2013-11-06 | $60.70M derived: sum of 4 quarters · filed 2014-03-07 | $480.67M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | $56.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $58.71M 10-Q · filed 2013-08-07 | $61.11M derived: sum of 3 quarters · filed 2014-03-07 | $60.93M derived: sum of 4 quarters · filed 2014-03-07 | $481.09M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | $2.67M 10-Q · filed 2013-05-08 | $5.06M derived: sum of 2 quarters · filed 2014-03-07 | $4.88M derived: sum of 3 quarters · filed 2014-03-07 | $24.53M derived: sum of 4 quarters · filed 2014-03-07 | $425.04M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $2.21M derived: sum of 2 quarters · filed 2014-03-07 | $21.87M derived: sum of 3 quarters · filed 2014-03-07 | $21.61M 10-K · filed 2014-03-07 | $422.37M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | -$179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $19.47M derived: sum of 2 quarters · filed 2012-11-07 | $19.22M 10-Q · filed 2012-11-07 | $24.03M derived: sum of 4 quarters · filed 2013-03-15 | $419.98M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | $19.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $19.40M 10-Q · filed 2012-08-06 | $24.21M derived: sum of 3 quarters · filed 2013-03-15 | $23.84M derived: sum of 4 quarters · filed 2013-03-15 | $420.16M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | -$253.00K 10-Q · filed 2012-05-04 | $4.56M derived: sum of 2 quarters · filed 2013-03-15 | $4.19M derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||
| 2010-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.44M derived: sum of 2 quarters · filed 2013-03-15 | $2.55M 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | -$372.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.27M 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | -$1.90M 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $28.81M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |